HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

J Bellmunt Selected Research

J Bellmunt Research Topics

Disease

16Neoplasms (Cancer)
01/2016 - 07/2000
11Urinary Bladder Neoplasms (Bladder Cancer)
02/2011 - 01/2000
8Renal Cell Carcinoma (Grawitz Tumor)
09/2015 - 10/2007
7Prostatic Neoplasms (Prostate Cancer)
09/2015 - 10/2008
5Carcinoma (Carcinomatosis)
01/2016 - 02/2012
5Neoplasm Metastasis (Metastasis)
02/2015 - 11/2011
4Transitional Cell Carcinoma
06/2013 - 09/2000
3Disease Progression
09/2013 - 03/2007
2Kidney Neoplasms (Kidney Cancer)
09/2015 - 09/2010
2Stomach Neoplasms (Stomach Cancer)
04/2013 - 03/2012
2Asthenia
08/2008 - 09/2000
1Anoxia (Hypoxia)
09/2013
1Esophageal Neoplasms (Esophageal Cancer)
03/2012
1Sarcoma (Soft Tissue Sarcoma)
07/2010
1Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
07/2010
1Colorectal Neoplasms (Colorectal Cancer)
03/2010
1Anemia
08/2008
1Hyperglycemia
08/2008
1Breast Neoplasms (Breast Cancer)
03/2007
1Liver Failure
04/2006
1Neutropenia
11/2001

Drug/Important Bio-Agent (IBA)

9Cisplatin (Platino)FDA LinkGeneric
04/2013 - 08/2003
6gemcitabineFDA Link
08/2007 - 07/2000
5Methotrexate (Mexate)FDA LinkGeneric
03/2009 - 01/2000
5Paclitaxel (Taxol)FDA LinkGeneric
03/2007 - 01/2000
4HormonesIBA
09/2015 - 10/2008
4zoledronic acid (zoledronate)FDA Link
09/2014 - 11/2011
4PlatinumIBA
11/2013 - 01/2002
3sunitinib (Sutent)FDA Link
09/2013 - 12/2011
3Biological Markers (Surrogate Marker)IBA
07/2013 - 10/2008
3sorafenib (BAY 43-9006)FDA Link
02/2013 - 10/2007
2vinflunineIBA
11/2013 - 06/2013
2Fluorouracil (Carac)FDA LinkGeneric
04/2013 - 03/2012
2oxaliplatin (Eloxatin)FDA LinkGeneric
03/2012 - 08/2007
2Carboplatin (JM8)FDA LinkGeneric
02/2012 - 11/2001
2docetaxel (Taxotere)FDA Link
11/2011 - 10/2008
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
03/2010 - 06/2003
2cetuximab (Erbitux)FDA Link
03/2010 - 06/2003
2Vinblastine (Vinblastine Sulfate)FDA Link
03/2009 - 05/2006
2Doxorubicin (Adriamycin)FDA LinkGeneric
03/2009 - 05/2006
1ParaffinIBA
04/2015
1Formaldehyde (Formol)FDA Link
04/2015
1Hemoglobins (Hemoglobin)IBA
02/2015
1Interleukin-2 (IL2)IBA
12/2014
1denosumabFDA Link
09/2014
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
09/2013
1P-GlycoproteinIBA
09/2013
1Proteins (Proteins, Gene)IBA
09/2013
1bevacizumabFDA Link
09/2013
1trabectedin (ecteinascidin 743)IBA
05/2012
1Interleukin-8 (Interleukin 8)IBA
12/2011
14- acetoxy- 13- ((3- ((tert- butoxycarbonyl)amino)- 2- hydroxy- 3- phenylpropanoyl)oxy)- 1- hydroxy- 7,10- dimethoxy- 9- oxo- 5,20- epoxytax- 11- en- 2- yl benzoateFDA Link
11/2011
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2011
1CytokinesIBA
09/2010
1Codon (Codons)IBA
07/2010
1Protein Kinases (Protein Kinase)IBA
03/2010
1AntibodiesIBA
03/2010
1Azacitidine (5 Azacytidine)FDA Link
09/2008
1Sirolimus (Rapamycin)FDA Link
08/2008
1temsirolimusFDA Link
08/2008
1Interferon-alpha (Interferon Alfa)FDA Link
08/2008
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
03/2007
1Caveolin 1IBA
03/2007
1Messenger RNA (mRNA)IBA
03/2007
1DNA (Deoxyribonucleic Acid)IBA
03/2007
1Drug CombinationsIBA
08/2003
1Monoclonal AntibodiesIBA
06/2003
1trastuzumab (Herceptin)FDA Link
06/2003
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2003
1Growth Factor ReceptorsIBA
06/2003
1gefitinib (Iressa)FDA Link
06/2003
1Epidermal Growth Factor (EGF)IBA
06/2003
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2003
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2003
1erlotinib (CP 358,774)FDA Link
06/2003
1TP protocolIBA
09/2000
1Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA
01/2000

Therapy/Procedure

13Drug Therapy (Chemotherapy)
01/2016 - 09/2001
3Castration
09/2014 - 11/2011
3Combination Drug Therapy (Combination Chemotherapy)
03/2009 - 08/2003
2Salvage Therapy
01/2016 - 02/2015
1Immunotherapy
09/2015
1Hepatectomy
04/2006
1Palliative Care (Palliative Medicine)
01/2002